Publications by authors named "Enric Vercher"

Claim this Profile
H
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice.
Enric Vercher, Ángela Covo-Vergara, Enrique Conde, Mercedes Hernández-Rueda, Edurne Elizalde

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma.
Enrique Conde, Noelia Casares, Uxua Mancheño, Edurne Elizalde, Enric Vercher

Mol Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.
Belén Aparicio, David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.
Smita S Chandran, Jiaqi Ma, Martin G Klatt, Friederike Dündar, Chaitanya Bandlamudi, Enric Vercher

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigens as potential vaccines in hepatocellular carcinoma.
David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.
Enrique Conde, Enric Vercher, Marta Soria-Castellano, Jesús Suarez-Olmos, Uxua Mancheño

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation and immunity in ovarian cancer.
Diego Salas-Benito, Enric Vercher, Enrique Conde, Javier Glez-Vaz, Ibon Tamayo

EJC Suppl· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis